All Infection Prevention & Control articles – Page 19
-
NewsMolecular mechanisms of fungal infections clarified
Researchers have clarified how fungal infections are regulated at molecular level, potentially leading to the development of new antifungal agents.
-
NewsNasal vaccine could be the new line of defence against Strep A
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
-
NewsWastewater surveillance research provides 12-day lead time for RSV season
Researchers using wastewater surveillance over conventional indicators have predicted the start of the annual respiratory syncytial virus (RSV) season 12 days early, providing more lead time for hospital preparedness.
-
NewsCovid-linked sepsis more common and deadly than previously thought
New research suggests that the virus responsible for COVID-19 was a more common and deadly cause of sepsis during the initial period of the pandemic than previously assumed.
-
NewsSource of sticking power for emerging fungal pathogen is uncovered
A previously uncharacterized adhesin protein specific to a human fungal pathogen plays a crucial role in the fungus’s ability to colonize a variety of living and non-living surfaces, and in its virulence, according to a new study.
-
NewsNew coronavirus-capturing material could transform the face mask
Researchers have developed a new material that captures coronavirus particles and could transform the efficiency of face masks.
-
NewsNew test for sepsis could save lives in emergency departments
Interdisciplinary research has found that a new blood test for sepsis could save lives and money.
-
NewsTiny nanocarriers could prove the magic bullet for acne sufferers
A new antibacterial compound was encased in tiny, soft nanoparticles 1000 times smaller than a single strand of human hair and applied in a gel form to targeted acne sites.
-
NewsScientists pioneer dual trojan horse approach to combat superbugs
In the relentless battle against antibiotic-resistant superbugs, science continues to unveil ingenious strategies to address their vulnerability. Like other bacteria, superbugs have a unique weakness – their dependence on iron for growth and survival. Iron serves as an essential nutrient that bacteria utilise for various cellular processes, including DNA replication, ...
-
NewsLeading scientists issue ‘gain of function’ recommendations
A workshop of leading scientists has reviewed the benefits and risks of ’gain of function’ research, and proposed a foundation to guide discussions and improve oversight moving forward.
-
NewsSurveillance system detected infection linked to eye drops months before outbreak declared
An infectious diseases surveillance system successfully flagged cases of a drug-resistant infection spread by eye drops months before national public health officials announced an outbreak.
-
OpinionEmerging risks in public health: is plastic pollution something to worry about?
Could plastic waste act as a vector for pathogens and contribute to the spread of infectious diseases?
-
NewsSepsis is as common as cancer, study reveals
A study in Sweden that more than four percent of all hospitalizations involved the patient suffering from sepsis, and 20 percent of all sepsis patients died within three months.
-
NewsDrinking water quality linked to lung infections in people with cystic fibrosis
High levels of some minerals and metals in environmental water supplies may increase the risk of nontuberculous mycobacteria (NTM) pulmonary infections in people with cystic fibrosis, according to a new study.
-
NewsResearchers on cusp of a new vaccine modality breakthrough
Researchers have succeeded in developing a new vaccine modality that is a stable particulate vaccine. The new vaccine modality is at proof-of-concept stage and in early development.
-
NewsGut microbiome can increase risk and severity of HIV and EBV disease
Researchers have shown that the microbiome has a significant impact on the acquisition of Epstein-Barr virus (EBV) and human immunodeficiency virus-1 (HIV) infection and plays a role in the course of disease.
-
NewsAcademic-private partnership aims to reduce toxic effects of deadly C. diff
The Center for One Health Research and Nectagen Inc. have received a nearly $275,000 grant to study whether synthetic proteins developed by Nectagen can reduce the toxicity of the digestive bacterium.
-
NewsMolnupiravir dose of human effect size-equivalent blocks Covid transmission in ferrets
Two oral drugs provide equivalent therapeutic benefit in preventing severe COVID-19 in animal models, but only molnupiravir efficiently blocked SARS-CoV-2 transmission when administered at a human effect size-equivalent dose.
-
NewsModulating type 1 Interferon may expand treatment options for COVID-19
Researchers have, for the first time in nonhuman primates, studied how modulating the signaling of type 1 Interferon (IFN-I), one of the body’s initial defenses against infection, impacts SARS-CoV-2 viral replication and disease progression.
-
NewsResearchers find chink in the armour of tuberculosis pathogen
Discovery of drug resistance network could clear way for developing a drug to prevent pathogen from resisting and tolerating tuberculosis treatment.
